Franco Gambazzi
Stage III N2 non-small cell lung cancer treatment: decision-making among surgeons and radiation oncologists
Glatzer M, Kocher G, Kraxner P, Krueger T, Martucci F, Oehler C, Ozsahin M, Papachristofilou A, Wagnetz D, Zaugg K, Zwahlen D, Opitz I, Kestenholz P, Karenovics W, Leskow P, Caparrotti F, Elicin O, Furrer M, Gambazzi F, Dutly A, Gelpke H, Guckenberger M, Heuberger J, Inderbitzi R, Cafarotti S, Putora P. Stage III N2 non-small cell lung cancer treatment: decision-making among surgeons and radiation oncologists. Transl Lung Cancer Res 2021; 10:1960-1968.
Apr 1, 2021Stage III N2 non-small cell lung cancer treatment: decision-making among surgeons and radiation oncologists
Apr 1, 2021Transl Lung Cancer Res 2021; 10:1960-1968
Glatzer Markus, Kocher Gregor Jan, Kraxner Peter, Krueger Thorsten, Martucci Francesco, Oehler Christoph, Ozsahin Mahmut, Papachristofilou Alexandros, Wagnetz Dirk, Zaugg Kathrin, Zwahlen Daniel, Opitz Isabelle, Kestenholz Peter, Karenovics Wolfram, Leskow Pawel, Caparrotti Francesca, Elicin Olgun, Furrer Markus, Gambazzi Franco, Dutly André, Gelpke Hans, Guckenberger Matthias, Heuberger Jürg, Inderbitzi Rolf, Cafarotti Stefano, Putora Paul Martin
Lung histology predicts outcome of bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation.
Holbro A, Lehmann T, Girsberger S, Stern M, Gambazzi F, Lardinois D, Heim D, Passweg J, Tichelli A, Bubendorf L, Savic S, Hostettler K, Grendelmeier P, Halter J, Tamm M. Lung histology predicts outcome of bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2013; 19:973-80.
Apr 2, 2013Lung histology predicts outcome of bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation.
Apr 2, 2013Biol Blood Marrow Transplant 2013; 19:973-80
Holbro Andreas, Lehmann Thomas, Girsberger Sabine, Stern Martin, Gambazzi Franco, Lardinois Didier, Heim Dominik, Passweg Jakob R, Tichelli André, Bubendorf Lukas, Savic Spasenija, Hostettler Katrin, Grendelmeier Peter, Halter Joerg P, Tamm Michael
Cancer/testis antigen expression and specific cytotoxic T lymphocyte responses in non small cell lung cancer
Groeper C, Gambazzi F, Zajac P, Bubendorf L, Adamina M, Rosenthal R, Zerkowski H, Heberer M, Spagnoli G. Cancer/testis antigen expression and specific cytotoxic T lymphocyte responses in non small cell lung cancer. Int J Cancer 2007; 120:337-43.
Jan 15, 2007Cancer/testis antigen expression and specific cytotoxic T lymphocyte responses in non small cell lung cancer
Jan 15, 2007Int J Cancer 2007; 120:337-43
Groeper Célia, Gambazzi Franco, Zajac Paul, Bubendorf Lukas, Adamina Michel, Rosenthal Rachel, Zerkowski Hans-Reinhard, Heberer Michael, Spagnoli Giulio C
Tissue microarray evaluation of Melanoma antigen E (MAGE) tumor-associated antigen expression: potential indications for specific immunotherapy and prognostic relevance in squamous cell lung carcinoma
Bolli M, Sauter G, Heberer M, Harder F, Gambazzi F, Mirlacher M, Haas P, Dalquen P, Guller U, Adamina M, Kocher T, Spagnoli G. Tissue microarray evaluation of Melanoma antigen E (MAGE) tumor-associated antigen expression: potential indications for specific immunotherapy and prognostic relevance in squamous cell lung carcinoma. Ann Surg 2002; 236:785-93; discussion 793.
Dec 1, 2002Tissue microarray evaluation of Melanoma antigen E (MAGE) tumor-associated antigen expression: potential indications for specific immunotherapy and prognostic relevance in squamous cell lung carcinoma
Dec 1, 2002Ann Surg 2002; 236:785-93; discussion 793
Bolli Martin, Sauter Guido, Heberer Michael, Harder Felix, Gambazzi Franco, Mirlacher Martina, Haas Philippe, Dalquen Peter, Guller Ulrich, Adamina Michel, Kocher Thomas, Spagnoli Giulio C